Evidence map›Paper›PMID 29911996›Full record

ArticleThe Journal of clinical investigation2018

Altered immune cell follicular dynamics in HIV infection following influenza vaccination.

Eirini Moysi, Suresh Pallikkuth, Lesley R De Armas, Louis E Gonzalez, David Ambrozak, Varghese George, David Huddleston, Rajendra Pahwa, Richard A Koup, Constantinos Petrovas and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Frontiers in immunology · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Eirini MoysiTissue Analysis Core, Immunology Laboratory, Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
Suresh PallikkuthDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Lesley R De ArmasDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Louis E GonzalezDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.
David AmbrozakImmunology Laboratory, VRC, NIAID, NIH, Bethesda, Maryland, USA.
Varghese GeorgeDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.
David HuddlestonDepartment of Trauma Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Rajendra PahwaDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Richard A KoupImmunology Laboratory, VRC, NIAID, NIH, Bethesda, Maryland, USA.
Constantinos PetrovasTissue Analysis Core, Immunology Laboratory, Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
Savita PahwaDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA.
University of Miami · US

Funding

University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ALLAN E RODRIGUEZ · 2007 to 2026
$33.8M
Tfh and B cells in HIV/SIV pathogenesis and vaccinationZIAAI005015 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KOUP, RICHARD A · 2009 to 2025
$24.1M
HIV/SIV Replication In VivoZIAAI005014 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KOUP, RICHARD A · 2009 to 2025
$22.7M
Antibody Responses in Aging SIV Infected MonkeysR01AI123048 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PAHWA, SAVITA, VILLINGER, FRANCOIS J · 2015 to 2019
$4.0M
Immunity and HIV persistence in perinatal HIV infectionR01AI127347 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PAHWA, SAVITA · 2016 to 2020
$3.3M
Antibody Responses in HIV and AgingR01AI108472 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PAHWA, SAVITA · 2013 to 2017
$2.9M
Vaccine-Induced memory CD4T cells and HIV reservoirsR56AI106718 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PAHWA, SAVITA · 2013 to 2013
$534k
NIAID NIH HHS P30 AI073961NIAID NIH HHS R01 AI108472NIAID NIH HHS R01 AI123048NIAID NIH HHS R01 AI127347NIAID NIH HHS R56 AI106718
6 · The paper itself

Abstract

HIV infection changes the lymph node (LN) tissue architecture, potentially impairing the immunologic response to antigenic challenge. The tissue-resident immune cell dynamics in virologically suppressed HIV+ patients on combination antiretroviral therapy (cART) are not clear. We obtained LN biopsies before and 10 to 14 days after trivalent seasonal influenza immunization from healthy controls (HCs) and HIV+ volunteers on cART to investigate CD4+ T follicular helper (Tfh) and B cell dynamics by flow cytometry and quantitative imaging analysis. Prior to vaccination, compared with those in HCs, HIV+ LNs exhibited an altered follicular architecture, but harbored higher numbers of Tfh cells and increased IgG+ follicular memory B cells. Moreover, Tfh cell numbers were dependent upon preservation of the follicular dendritic cell (FDC) network and were predictive of the magnitude of the vaccine-induced IgG responses. Interestingly, postvaccination LN samples in HIV+ participants had significantly (P = 0.0179) reduced Tfh cell numbers compared with prevaccination samples, without evidence for peripheral Tfh (pTfh) cell reduction. We conclude that influenza vaccination alters the cellularity of draining LNs of HIV+ persons in conjunction with development of antigen-specific humoral responses. The underlying mechanism of Tfh cell decline warrants further investigation, as it could bear implications for the rational design of HIV vaccines.

Indexed as

AdultAntiretroviral Therapy, Highly ActiveB-LymphocytesCase-Control StudiesFemaleHIV InfectionsHumansInfluenza VaccinesLymph NodesLymphocyte CountMaleMiddle AgedT-Lymphocytes, Helper-InducerVaccinationInfluenza VaccinesAIDS/HIVAIDS vaccineB cellsImmunologyT cells

Identifiers

PMID29911996
PMCPMC6025971
OpenAlexW2808210430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.